Home › UPDATE 1-U.S. health insurers say Gilead hepatitis C drug too costly
 

Keywords :   


UPDATE 1-U.S. health insurers say Gilead hepatitis C drug too costly

2014-05-21 03:50:55| Biotech - Topix.net

The leading U.S. health insurance trade group on Tuesday hit out at the extremely high cost of new specialty medicines, accusing drugmakers of taking advantage of the insurance system by pricing products at unsustainable levels.

Tags: health too update drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
19.05Cashing In On The Stache
19.05 Dr. Squatch Launches Bronco Bricc
19.05Gillette Venus Announces Ambassadors Ahead of the Olympic and Paralympic Games Paris 2024
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05'I had no choice but to get a 35-year mortgage'
More »